These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2566321)

  • 21. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG; Shanks RG; Brogden RN
    Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic effects of intravenously administered celiprolol in patient with coronary heart disease and depressed left ventricular function].
    Leisch F; Herbinger W
    Arzneimittelforschung; 1987 Apr; 37(4):444-6. PubMed ID: 2886131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of celiprolol compared to propranolol on thyroid metabolism].
    Langsteger W; Lind P; Eber O
    Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
    van der Woude HJ; Zaagsma J; Postma DS; Winter TH; van Hulst M; Aalbers R
    Chest; 2005 Mar; 127(3):818-24. PubMed ID: 15764762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of the cardioselective beta blocker celiprolol on pulmonary function in asthmatic patients.
    Schindl R; Würtz J; Hoffmann H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S99-101. PubMed ID: 2427862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high doses of celiprolol in asthmatic patients.
    Doshan HD; Brown R; Applin WJ; Kapoor M; Caruso FS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S109-11. PubMed ID: 2427837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
    Perrone MH; Barrett JA
    Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different effects of beta-1-adrenergic blocking agents with ISA or without ISA on peripheral blood flow.
    Karnik R; Valentin A; Slany J
    Angiology; 1987 Apr; 38(4):296-303. PubMed ID: 2883920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.
    McLenachan JM; Grant S; Ford I; Henderson E; Dargie HJ
    Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.
    Cadigan PJ; London DR; Pentecost BL; Bianchetti G; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Jun; 9(6):569-75. PubMed ID: 6104498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.